Paper19005182
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group.
Rodeghiero F and 19 others. Blood, 2009. Cited by 2,070 papers, by iCite.
Cite this record
ConductScience Library. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Papers, record 19005182. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19005182
- Disease
- autoimmune thrombocytopenic purpura105 drugs
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group.
- PubMed
Connected records1
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Purpura, Thrombocytopenic, Idiopathic | Major topic |
| Terminology as Topic | Major topic |
| Health Planning Guidelines | |
| Humans | |
| International Cooperation | |
| Reference Standards | |
| Treatment Outcome |
Source PubMed
Trials26
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT01356511 | High-dose Dexamethasone Versus Conventional Dose Prednisone for Initial Treatment of Primary Immune Thrombocytopenia (ITP) | Background | ClinicalTrials.gov | |
| NCT01506414 | Recombinant Human Thrombopoietin in Combination With Rituximab in Immune Thrombocytopenia (ITP) | Background | ClinicalTrials.gov | |
| NCT01525836 | rhTPO Combining Rituximab Versus Low-dose Rituximab in Management of ITP | Background | ClinicalTrials.gov | |
| NCT01667263 | The Combination of ATRA and Danazol as Second-line Treatment in Adult Immune Thrombocytopenia | Background | ClinicalTrials.gov | |
| NCT01727999 | Genome-Wide Gene Expression Profiling of Patients With ITP Receiving Thrombopoietin Mimetics | Background | ClinicalTrials.gov | |
| NCT01734044 | rhTPO Combining Dexamethasone Versus High-dose Dexamethasone for Initial Treatment of ITP | Results | ClinicalTrials.gov | |
| NCT01734057 | Recombinant Human Thrombopoietin (rhTPO) Combining Rituximab Versus High-dose Dexamethasone for Initial Treatment of Primary Immune Thrombocytopenia (ITP) | Results | ClinicalTrials.gov | |
| NCT01965626 | A Multicenter Randomized Open-label Study of Oseltamivir Combined With HD-DEX Versus HD-DEX in the Management of ITP | Results | ClinicalTrials.gov | |
| NCT02153060 | An Investigation of Dexamethasone With Different Doses in the Management of Immune Thrombocytopenia (ITP) | Background | ClinicalTrials.gov | |
| NCT02834468 | DEX Combined With RTX, CSA and IVIG in the Management of Newly Diagnosed ITP Patients | Background | ClinicalTrials.gov | |
| NCT02892630 | Immune Thrombocytopenia in Pregnancy | Background | ClinicalTrials.gov | |
| NCT02914054 | Therapy of Adults Affected by Idiopathic Thrombocytopenic Purpura With Dexamethasone | Background | ClinicalTrials.gov | |
| NCT03252457 | Decitabine Combining Dexamethasone Versus Dexamethasone in Management of ITP | Results | ClinicalTrials.gov | |
| NCT03412188 | The Effect of Eltrombopag on the Expression of Platelet Collagen Receptor GPVI in Pediatric ITP. | Results | ClinicalTrials.gov | |
| NCT03754634 | A Prospective, Open, Multicenter Clinical Trial of Eltrombopag Combined With Diacerein in Eltrombopag-inefficient or Relapsed ITP | Results | ClinicalTrials.gov | |
| NCT03771378 | Efficacy and Safety of rhTPO and Eltrombopag in Patients With Primary Immune Thrombocytopenia (ITP) | Results | ClinicalTrials.gov | |
| NCT04113915 | Viral Hepatitis B and C Infection in Patients With Idiopathic Thrombocytopenic Purpura Treated With Triple Therapy | Background | ClinicalTrials.gov | |
| NCT04128358 | Triple Therapy in Patients With Idiopathic Thrombocytopenic Purpura : What is Behind? | Background | ClinicalTrials.gov | |
| NCT04917679 | Eltrombopag Plus Diacerein vs Eltrombopag in Adult ITP | Background | ClinicalTrials.gov | |
| NCT05411874 | A Multicenter Randomized Open-label Study of Chidamide Plus HD-DEX Versus HD-DEX in ITP | Background | ClinicalTrials.gov |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 19713486 | Antinuclear antibody (ANA)-positive thrombocytopenia: primary, but with a difference. | https://conductscience.org/library/papers/19713486 |
Source PubMed
Cited by963
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2,070 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42967207 | Immune Thrombocytopenia Following COVID-19 Vaccination in a Pediatric Patient. | Cureus | 2026 | https://conductscience.org/library/papers/42967207 | PubMed |
| 42945908 | Update of the Brazilian Clinical Practice Guideline for primary immune thrombocytopenia: methodological process and main changes for diagnosis and treatment in the Brazilian Unified Health System (SUS). | Hematol Transfus Cell Ther | 2026 | https://conductscience.org/library/papers/42945908 | PubMed |
| 42936669 | Severe Immune Thrombocytopenia Associated With Newly Diagnosed Rheumatoid Arthritis and Complicated by a Spontaneous Presacral Haematoma: A Case Report. | Cureus | 2026 | https://conductscience.org/library/papers/42936669 | PubMed |
| 42927077 | Treatment patterns and safety outcomes after splenectomy or thrombopoietin receptor agonists as second-line therapy for immune thrombocytopenia: Korean claims-based study. | Res Pract Thromb Haemost | 2026 | https://conductscience.org/library/papers/42927077 | PubMed |
| 42907786 | Initial response and long-term prognostic risk factors in pediatric ITP. | BMC Pediatr | 2026 | https://conductscience.org/library/papers/42907786 | PubMed |
| 42867565 | β2-adrenergic receptor agonist regulates macrophage polarization via HMGB1 in immune thrombocytopenia. | Sci China Life Sci | 2026 | https://conductscience.org/library/papers/42867565 | PubMed |
| 42866340 | Thrombocytopenia: from physiological homeostasis imbalance to mechanism-driven precision diagnosis and therapy. | Front Immunol | 2026 | https://conductscience.org/library/papers/42866340 | PubMed |
| 42866218 | The prediction of disease chronicity when immune thrombocytopenia is first diagnosed. | Transl Pediatr | 2026 | https://conductscience.org/library/papers/42866218 | PubMed |
| 42821196 | Unveiling the role of circulating monocyte-macrophage polarization state and PD-L1/PD-L2 expression in newly diagnosed pediatric ITP. | Blood Res | 2026 | https://conductscience.org/library/papers/42821196 | PubMed |
| 42780154 | Long-term outcomes of eltrombopag plus cyclosporine A in eltrombopag-exposed patients with glucocorticoid-resistant or -dependent primary immune thrombocytopenia: a prospective, multicenter, single-arm, phase II study with extended follow-up. | Front Immunol | 2026 | https://conductscience.org/library/papers/42780154 | PubMed |
| 42780051 | Artificial intelligence prediction of therapy response in newly diagnosed adult severe primary immune thrombocytopenia. | Res Pract Thromb Haemost | 2026 | https://conductscience.org/library/papers/42780051 | PubMed |
| 42761734 | Longitudinal Divergence Between CONUT and GNRI Following Decreased Food Intake Temporally Associated With Trimethoprim-Sulfamethoxazole Administration in an Older Patient With Immune Thrombocytopenia and Dementia: A Case Report. | Cureus | 2026 | https://conductscience.org/library/papers/42761734 | PubMed |
| 42751632 | Cytomegalovirus-Associated Thrombocytopenia in an Immunocompetent Infant: A Case Report. | Pediatric Health Med Ther | 2026 | https://conductscience.org/library/papers/42751632 | PubMed |
| 42730410 | Evolving Paradigms in the Management of Primary Immune Thrombocytopenia in Adults: From Corticosteroids to Targeted Therapies. | Mediterr J Hematol Infect Dis | 2026 | https://conductscience.org/library/papers/42730410 | PubMed |
| 42713481 | Diagnostic Utility of Platelet Indices in Differentiating Hypoproductive and Hyperdestructive Thrombocytopenia: A Cross-Sectional Study From North India. | Cureus | 2026 | https://conductscience.org/library/papers/42713481 | PubMed |
| 42707190 | Cost-effectiveness analysis of eltrombopag, hetrombopag and romiplostim for second-line treatment of primary immune thrombocytopenia in China. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42707190 | PubMed |
| 42698986 | Dual Autoimmunity: Evans Syndrome and Multiple Sclerosis. | Cureus | 2026 | https://conductscience.org/library/papers/42698986 | PubMed |
| 42678489 | Early Use of Fostamatinib in Immune Thrombocytopenia. | Adv Ther | 2026 | https://conductscience.org/library/papers/42678489 | PubMed |
| 42675186 | Redefining neonatal thrombocytopenia: an evidence-based approach, improved by the refineR algorithm. | J Perinatol | 2026 | https://conductscience.org/library/papers/42675186 | PubMed |
| 42662888 | Avatrombopag in thrombopoietin receptor agonist-naïve patients with immune thrombocytopenia: real-world treatment patterns and clinical outcomes from the REAL-AVA 3.0 study. | Res Pract Thromb Haemost | 2026 | https://conductscience.org/library/papers/42662888 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| KRT20 | 54474 | PubTator's text mining | https://conductscience.org/library/genes/54474 | NCBI Gene |
| MPL | 4352 | PubTator's text mining | https://conductscience.org/library/genes/4352 | NCBI Gene |
Drugs10
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets | Source |
|---|---|---|---|---|---|
| DECITABINE | CHEMBL1201129 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL1201129 | ChEMBL |
| RITUXIMAB | CHEMBL1201576 | Results | 2 | https://conductscience.org/library/drugs/CHEMBL1201576 | ChEMBL |
| ROMIPLOSTIM | CHEMBL1201832 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL1201832 | ChEMBL |
| OSELTAMIVIR | CHEMBL1229 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL1229 | ChEMBL |
| AVATROMBOPAG | CHEMBL2103883 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL2103883 | ChEMBL |
| DEXAMETHASONE | CHEMBL384467 | Results | 3 | https://conductscience.org/library/drugs/CHEMBL384467 | ChEMBL |
| DIACEREIN | CHEMBL41286 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL41286 | ChEMBL |
| RAFUTROMBOPAG | CHEMBL4594401 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL4594401 | ChEMBL |
| ELTROMBOPAG | CHEMBL461101 | Results | 4 | https://conductscience.org/library/drugs/CHEMBL461101 | ChEMBL |
| RECOMBINANT HUMAN THROMBOPOIETIN | CHEMBL4802180 | Results | 3 | https://conductscience.org/library/drugs/CHEMBL4802180 | ChEMBL |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- References
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19005182
GET https://conductscience.org/api/papers/v1/19005182/trials?page=2